GIPR

Cambridge study solves weight loss drug paradox

Scientists at the University of Cambridge have resolved a longstanding puzzle in obesity pharmacology: why both activating and blocking the same receptor can lead to weight loss. The answer, published July 24 in Nature Metabolism, lies in two anatomically separate…